I n recent years, it has been possible to induce dominant and infectious tolerance to allogeneic transplants by short-term use of mAb blocking either T cell coreceptors or costimulatory molecules (1, 2). Such tolerance is mediated, in part, by Agspecific CD4 ϩ regulatory T (Treg) 4 cells. In the steady state, Treg cells have specificity for fragments of donor Ags presented by host MHC molecules (3), suggesting that processing by host APC is required. However, within the tolerant host, such Ag-laden APC would be considered quiescent and ignorant of "danger" signals. This suggests that quiescent or resting APC have the intrinsic ability not only to induce tolerance, but to drive uncommitted T cells toward a regulatory function. This possibility has been highlighted by recent studies using A1.RAG-1 Ϫ/Ϫ mice, a TCR-transgenic strain in which all CD4 ϩ T cells are specific for a defined peptide from the male minor histocompatibility Ag, Dby. Although these animals carry no natural Treg cells, "vaccination" with either the antigenic peptide (4) or an appropriate altered peptide ligand (APL) (5) results in tolerance through the induction of adaptive Treg cells. The assumption is that the relevant peptide is presented by quiescent, host APC. In this study, we directly test whether quiescent dendritic cells (DC) can achieve the same result by examining the outcome of vaccination with Ag-presenting DC, modulated to exhibit different degrees of activation. Bone marrowderived DC (bmDC), activated through TLR4, were not competent to tolerize. By contrast, DC that had not been TLR activated induced both tolerance and regulation. Pharmacological modulation by 1␣, 25-dihydroxyvitamin D 3 (1␣,25(OH) 2 D 3 ), an analog of vitamin D 3 known to constrain DC maturation (6), evoked dominant tolerance irrespective of any additional TLR stimulation. We conclude that DC that are unable to deliver full activation signals may, by default, induce tolerance, T cell unresponsiveness, and Treg cells.
fixation to enable the exclusion of debris and nonviable cells. Four-color analysis was performed using a FACSCalibur (BD Biosciences) with CellQuest 3.1 software.
ELISA
Day 6 bmDC generated with or without 1␣,25(OH) 2 D 3 were plated in equal numbers (10 6 /ml) in R10 medium supplemented with 20 ng/ml IFN-␥ Ϯ 1␣,25(OH) 2 D 3 Ϯ 1 g/ml LPS. After incubation for 24 h, culture supernatants were assayed using an IL-12p70 Duoset ELISA kit (R&D Systems), calibrated against a standard dilution series of recombinant mouse IL-12 p70, according to the manufacturer's instructions. IL-10 secretion was assessed using a bead-based assay and analyzed on a Bio-Plex System machine using Bioplex Manager Software 4.0 (Bio-Rad).
T cell proliferation assay
To assess the capacity of modified male CBA/Ca DC to stimulate primary responses, nylon wool-purified splenocytes from naive, female A1.RAG-1 Ϫ/Ϫ mice were cultured in triplicate with varying numbers of DC. To assess T cell responses from grafted A1.RAG-1 Ϫ/Ϫ mice, nylon woolpurified splenocytes (5 ϫ 10 4 /well) were cocultured with mitomycin Ctreated immature female CBA/Ca-derived bmDC (1 ϫ 10 4 /well) and Dby peptide at a final concentration of 1, 10, or 100 nM, as appropriate. Responder spleen cell suspensions were nylon wool-purified and depleted of RBC by Tris-buffered ammonium chloride lysis, washed, and cultured in 96-well round-bottom plates at 5 ϫ 10 4 cells/well in R10 medium. Stimulators were prepared by treating bmDC with 10 g/ml mitomycin C for 30 min at 37°C and were titrated into cocultures. After incubating for 72 h, cocultures were pulsed with 0.5 Ci/well [ 3 H]TdR (Amersham International) for a further 18 -24 h. Incorporation was measured after 18 -24 h using a flat-bed scintillation counter (LBK Wallac).
Tolerance induction and skin grafting
Age-matched female A1.RAG-1 Ϫ/Ϫ mice were given a single i.v. injection of 2 ϫ 10 6 bmDC in PBS. Control mice received PBS alone. Twenty eight days later, skin grafting was performed by transplanting full thickness tail skin (1 cm 2 ) from male CBA/Ca.RAG-1 Ϫ/Ϫ mice onto the lateral flank, as previously described (8) . Grafts were observed after the removal of the plaster cast at day 7 and considered rejected when no donor skin could be identified.
Isolation of cells from tolerated grafts
T cells were prepared from tolerated skin grafts by cutting them into small pieces, digesting with 0.125% (v/v) trypsin at 37°C for 1 h, and removing dead cells by passage over nylon wool. Viable lymphocytes were enriched by Histopaque-1083 centrifugation (Sigma-Aldrich). Total cell infiltrates, consisting of ϳ5 ϫ 10 3 CD4 ϩ T cells per graft, were characterized either by real-time PCR or flow cytometry.
Real-time quantitative PCR
DNase-I-treated total RNA was prepared from tissues using the SV Total RNA isolation system (Promega). Reverse transcription was performed using the Prostar First Strand Synthesis kit (Stratagene), primed with random hexamers. Multiplex PCR was performed using gene-specific primers, fluorogenic probes, and the Universal MasterMix kit (Applied Biosystems) in triplicate with primers at a concentration of 300 nM and the probe at 200 nM. A two-step PCR procedure of 15 s at 95°C and 60 s at 60°C was applied for 50 cycles. PCR and TaqMan analysis was performed using the ABI/PRISM 7700 Sequence Detector System (Applied Biosystems). Standard curves of appropriate cDNAs were used to calibrate threshold cycles to amounts of test and normalizing cDNAs on each 96-well sample plate. Normalized values for mRNA expression were calculated as test mean/ normalizer mean. Forward and reverse primer sequences and TaqMan probes (Eurogentec) were as follows: foxp3, forward: 5Ј-CCCAGGAAA GACAGCAACCTT-3Ј, reverse: 5Ј-TTCTCACAACCAGGCCACTTG-3Ј; TaqMan probe: FAM-5Ј-CTACCCACTGCTGGCAAATGGAGTC-3Ј-TAMRA; CD3␥, forward: 5Ј-TTACAGAATGTGTGAAAACTGCATTG-3Ј, reverse: 5Ј-CACCAAGAGCAAGGAAGAAGATG-3Ј; TaqMan probe: VIC-5Ј-ACATAGGCACCATATCCGGCTTTTCTTCG-3Ј-TAMRA.
Cell separation

Separation of CD4
ϩ CD25 Ϫ and CD4 ϩ CD25 ϩ cells was performed similar to the method described in Graca et al. (9) . Briefly, to obtain a population of splenic CD4 ϩ cells, splenocytes were incubated with the MACS CD4 ϩ T cell isolation kit biotin-Ab mixture (Miltenyi Biotec) according to the manufacturer's instructions, and positively selected over two magnetic columns using the "POSSELD" program of AutoMACS (Miltenyi Biotec). CD4 ϩ CD25 Ϫ cells were sorted from the CD4 ϩ CD25 ϩ fraction by incubation with biotinylated anti-CD25 Ab (clone 7D4; BD Pharmingen) for 20 min at 4°C. After washing, the cells were incubated with streptavidin microbeads (Miltenyi Biotec) and were selected using the AutoMACS POSSEL program, according to the manufacturer's instructions. Typically, the purity of CD4 ϩ CD25 Ϫ T cells exceeded 90% of total CD4 ϩ T cells. The purity of the CD4 ϩ CD25 ϩ T cells routinely exceeded 80% of total CD4 ϩ T cells.
Microarray analysis
Custom immune system-directed microarrays were prepared using 70-mer probes specific for 768 genes. Each probe was printed with four nonadjacent replicates onto Genetix amine slides with a QArray mini microarray printer using 150-m aQu tungsten pins. A full description of the microarray is available from ArrayExpress (accession number: A-MEXP-239).
The integrity of RNA was validated using a 2100 BioAnalyser (Agilent). Total RNA was reverse transcribed using Superscript III and was otherwise processed and labeled as directed using the Cy3 and Cy5 3DNA 900 Dendrimer Labeling kit (Genisphere) and a two-step hybridization protocol with on-slide mixing on a Slide Booster (Advalytix). Arrays were scanned at 5-m resolution using autocalibration for a peak target saturation of 95% using a ScanArray Express HT scanner (PerkinElmer). Image analysis was performed using BlueFuse version 2 (BlueGnome) and, following manual exclusion of artifacts, replicate data were combined using the fusion algorithm. Further analysis of the data was performed in Microsoft Excel to correct for channel overlap and globally normalize expression signals. Microarray data are available at the EMBL-EBI ArrayExpress database (accession number: E-MEXP-506).
Statistical analysis
Statistical analysis of graft survival was assessed by means of the log-rank method. Differences in median graft survival were considered significant for p Ͻ 0.05 (one-tailed test). For microarray analysis, fold changes were considered significant if they exceeded 2-fold and were Ͼ2.0 SD from the geometric mean (geometric mean fold changes were 0.77, 1.76, 0.52, and 1.42 for DCo, DCv, DCo ϩ , and DCv ϩ , respectively; n ϭ 766).
Results
Phenotypic and functional characterization of DC populations
We wished to determine whether DC incapacitated for full activation are able to induce tolerance and regulation in vivo. We used bmDC as a source of immature DC (DCo), and cells treated with 1 g/ml LPS for the final 18 h of culture, as a source of fully activated DC (DCo ϩ ) with the ability to present peptide to naive T cells in an optimal fashion. Because immature DC might, in theory, mature when injected into recipients, we also preincubated these cells with 1␣,25(OH) 2 D 3 , known to impair their full maturation. Immunostaining for MHC class II and costimulatory molecules, in vitro functional assays, and transcriptional gene profiling were used to validate the effects of LPS and the pharmacological efficacy of 1␣,25(OH) 2 D 3 treatment.
Consistent with previous findings (6, 10, 11), the surface expression of MHC class II was significantly reduced in cultures supplemented with 10 Ϫ7 M 1␣,25(OH) 2 D 3 (DCv) compared with untreated controls (DCo) (Fig. 1A ). Whereas DCo ϩ were able to up-regulate MHC class II and CD86 upon TLR4 stimulation with LPS, DCv ϩ were substantially impaired in this respect (Fig. 1A) . The restraining effect of 1␣,25(OH) 2 D 3 was further evident from the inability of DCv to secrete significant levels of IL-12p70 in response to a combination of LPS and IFN-␥, compared with control DC, cultured without further stimulation (Fig. 1B) . In contrast,
DCv
ϩ were found to secrete elevated levels of IL-10 compared with other populations, as previously documented (11) (Fig. 1B) . These phenotypic and functional changes were accompanied by the reduced capacity of 1␣,25(OH) 2 D 3 -treated male CBA/Ca DC to stimulate proliferation of naive female A1.RAG-1 Ϫ/Ϫ T cells when compared with untreated controls (Fig. 1C) . Indeed, DCv were unable to elicit any detectable proliferative response among naive T cells, confirming previous reports of the immunomodulatory effects of vitamin D 3 and its analogs (6, 10, 11) and drawing close parallels with DC modulated by exposure to IL-10 and TGF-␤ (A. Paterson, C. Farquhar, S. Cobbold, H. Garcia Rueda, S. Yates, P. Fairchild, N. Saunders, H. Waldmann, and K. Nolan, manuscript in preparation) (12) .
Validation of DC populations by gene expression profiling
Differences in the LPS responsiveness of untreated DC and DC modulated with 1␣,25(OH) 2 D 3 were reflected in their patterns of gene expression, as evidenced by microarray. Total RNA from DCo, DCv, DCo ϩ , and DCv ϩ populations was used to analyze transcriptional changes in 786 immunologically relevant genes represented on a custom-designed oligoprobe microarray. Data are presented in Table I as fold changes from the overall mean of the four populations. In keeping with the differential response to LPS observed by flow cytometry, 24 of the 786 genes exhibited at least a 2-fold increase from the geometric mean only among DC treated with LPS in the absence of exposure to 1␣,25(OH) 2 D 3 (Table I , section I). These included CCR7, known to facilitate full maturation and homing of licensed DC (13) , and the chemokines CCL22 and CXCL16, which attract recently activated and memory T cells. Other examples included a number of classic proinflammatory genes, such as those encoding the chemokines DCIP-1, CXCL1, and the cytokine, IL-1, the LPS responsiveness of which was retained in IL-10-modulated DC that have been implicated in tolerance induction (14) . MHC class II, CD83, 4-1BB, MARCO, PD-L1, and CD40 are all surface molecules well-documented to increase following TLR-induced DC maturation. Nevertheless, these were not up-regulated following pretreatment with 1␣,25(OH) 2 D 3 ; other genes implicated in Th1 induction, such as STAT4 (15), IL-12p40 (16, 17) , and IL-27 (18, 19) were likewise not up-regulated, as were IRF-5 and -7, important in MyD88-dependent TLR signaling (20, 21). Twelve gene changes were observed that were unique to the 1␣,25(OH) 2 D 3 -modulated DC (Tables I, sections II and III) , confirming the biological activity of the reagent used and its impact on gene expression. Interestingly, only 1 of the 768 genes analyzed, that encoding the chemokine TARC (CCL17), was specifically down-regulated in response to treatment with 1␣,25(OH) 2 D 3 (Table I, section II), consistent with previous observations of the effect of this agent on human myeloid DC (22 (Fig. 2A) . Preliminary studies indicated that as few as 2 ϫ 10 6 immature male DC per mouse were capable of achieving durable engraftment of male skin, transplanted 28 days later. Using this protocol, 100% of mice treated with either of the immature populations of DC (DCo or DCv) accepted their grafts indefinitely (n ϭ 19 in each case). In contrast, mice that had received LPS-matured DC (DCo ϩ ) (n ϭ 16) did not become tolerant but rejected male skin grafts with a median survival time of 13 days. Remarkably, DC that had been cultured with 1␣,25(OH) 2 D 3 before LPS exposure (DCv ϩ ) induced 100% acceptance of male skin grafts (n ϭ 15). By comparison, all control mice receiving treated populations of syngeneic DC derived from female CBA/Ca donors rejected their grafts (Fig. 2B) , indicating the Agdependent nature of tolerance induction. In all cases, mice that accepted their skin grafts, also accepted a second graft 100 days later, confirming that a form of tolerance had been established that persisted long after the demise of the DC responsible for its induction.
Transplantation tolerance induced by DC is dominant
One of the cardinal features of dominant tolerance mediated by Treg cells is resistance to the rejection of established or fresh grafts by newly infused immunocompetent lymphocytes. To investigate the nature of the tolerant state induced by DC, 10 7 splenocytes from naive female A1.RAG-1 Ϫ/Ϫ mice were administered to mice that had accepted male skin grafts. All mice previously rendered tolerant still retained both of their existing grafts and accepted fresh skin grafts indefinitely. In contrast, all control female CBA/ Ca.RAG-1 Ϫ/Ϫ mice, receiving the same number of naive splenocytes, rapidly rejected male skin grafts (n ϭ 5) (Fig. 2C) .
Tolerance induced by DC does not require reprocessing of donor Ags
The induction of transplantation tolerance by donor-specific transfusion of spleen cells has been shown to be mediated through the reprocessing of donor Ag by host DC (23), as has that mediated by uptake of apoptotic cells (24, 25) . To investigate the possibility of host reprocessing in our studies, we examined the tolerizing mice received one dose of either PBS alone (F) (n ϭ 16) or 2 ϫ 10 6 male CBA/Ca DC (‚, DCo (n ϭ 19); Ⅺ, DCv (n ϭ 19); OE, DCo ϩ (n ϭ 16); f, DCv ϩ (n ϭ 15)). After 28 days, recipient mice were grafted with male CBA/Ca.RAG-1 Ϫ/Ϫ skin grafts and were monitored for a further 100 days. B, Tolerance induction is Ag specific. Female A1.RAG-1 Ϫ/Ϫ mice were treated with one dose of PBS alone (F) (n ϭ 5) or 2 ϫ 10 6 female CBA/Ca DC (‚, DCo,; Ⅺ, DCv; OE, DCo ϩ ; f, DCv ϩ ) and were grafted 28 days later with male CBA/Ca.RAG-1 Ϫ/Ϫ skin (for all groups n ϭ 5). C, The form of tolerance induced by DC is dominant. After 100 days, each group of female A1.RAG-1 Ϫ/Ϫ mice which had received male CBA/Ca DC was infused with 10 7 naive A1.RAG-1 Ϫ/Ϫ splenocytes and a fresh male CBA/Ca.RAG-1 Ϫ/Ϫ skin graft was applied a day later (‚, DCo (n ϭ 6); Ⅺ, DCv (n ϭ 6); OE, DCo ϩ (n ϭ 5); f, DCv ϩ (n ϭ 5)). Positive rejection controls consisted of age-matched female CBA/Ca.RAG-1 Ϫ/Ϫ mice infused with 10 7 naive A1.RAG-1 Ϫ/Ϫ splenocytes and given a fresh male CBA/Ca.RAG-1 Ϫ/Ϫ skin graft a day later (F) (n ϭ 6). D, Tolerance induction does not require processing of Dby by host DC. Female A1.RAG-1 Ϫ/Ϫ mice were treated with one dose of PBS alone (F) (n ϭ 5) or 2 ϫ 10 6 male C57BL/10 DC (‚, DCo; Ⅺ, DCv; OE, DCo ϩ ; f, DCv ϩ ). Mice were grafted 28 days later with male CBA/Ca.RAG-1 Ϫ/Ϫ skin (n ϭ 5 for all groups).
potential of male DC from C57BL/10 mice. Such DC express the H-2 b haplotype and are, therefore, unable to present the Dby epitope directly to TCR-transgenic, H-2E k -restricted A1.RAG-1 Ϫ/Ϫ T cells. Recipient A1.RAG-1 Ϫ/Ϫ mice remained unchanged in their ability to reject male CBA/Ca.RAG-1 Ϫ/Ϫ skin grafts following infusion of male C57BL/10 DC, whether or not they had been pharmacologically conditioned with 1␣,25(OH) 2 D 3 . These results confirm the need for cognate interactions between administered DC and alloreactive T cells and exclude the possibility that administered DC serve solely as a source of the Dby Ag, presented to naive T cells by endogenous DC (Fig. 2D) .
De novo generation of CD4
ϩ CD25 ϩ cells in the periphery of tolerant mice
CD4
ϩ T cells in the spleens of tolerant mice remained numerically unchanged when compared with naive, age-matched mice, indicating that tolerance was not accompanied by the gross deletion of T cells (Table II) . In fact, in tolerized mice, the total number of splenocytes ranged from 2.05 ϫ 10 7 to 3.58 ϫ 10 7 , which was barely different from controls.
The A1.RAG-1 Ϫ/Ϫ strain cannot produce natural CD4 ϩ CD25 ϩ foxp3 ϩ Treg cells centrally within the thymus. Any T cells expressing this phenotype that arise following administration of DC must, therefore, have been induced in the periphery de novo. In all tolerant mice, irrespective of the DC population administered, the absolute number of CD4 ϩ CD25 ϩ cells was significantly increased, ranging from 12.9 to 20.6% of the total CD4 ϩ population, compared with 4.6% among PBS-treated control mice and 4.3% among mice which had received DCo ϩ (Table II) . Quantitative real-time PCR analysis of foxp3 mRNA expression by splenocytes from tolerant, rejecting, and control mice, normalized to CD3␥ to correct for T cell content, showed elevated levels in tolerant, compared with control or rejecting, splenocytes (Fig. 3A) . In subsequent studies, mRNA levels have been shown to correlate precisely with expression of the foxp3 protein, as determined by flow cytometry, suggesting a positive correlation between the appearance of a CD4 ϩ CD25 ϩ foxp3 ϩ population of Treg cells and the induction of dominant tolerance in our model (26, 27) . These conclusions are further supported by flow cytometric analysis of the CD4 ϩ CD25 ϩ population from tolerant mice which showed increased expression of GITR and CD103 compared with CD4 ϩ
CD25
Ϫ splenocytes (Fig. 3B) , consistent with a regulatory phenotype (28 -30) . Importantly, these T cells must have been derived de novo from the naive CD4 ϩ CD25 Ϫ GITR Ϫ CD103 Ϫ foxp3 Ϫ population of recipient T cells, because all skin grafts were derived from T cell-deficient CBA.RAG-1 Ϫ/Ϫ donors. The above findings are in marked contrast to the thymus where we observed no increase in either total thymocyte numbers or CD4 ϩ CD25 ϩ cells, indicating no effect on central tolerance processes (Table II) .
cells infiltrate tolerated skin grafts
Previous data from our laboratory have documented how CD4 ϩ CD25 ϩ foxp3 ϩ Treg cells may be isolated from skin grafts accepted through dominant tolerance (5, 31) . Consistent with this finding, we observed an increase in relative foxp3 mRNA expression among graft-infiltrating cells from tolerant mice (Fig. 4A) , while analysis of cells infiltrating the grafts of mice tolerized with either DCo or DCv revealed the appearance of CD25 ϩ GITR ϩ cells which represented ϳ30 -40% of CD4 ϩ cells (Fig. 4B ).
Both CD4
ϩ CD25 Ϫ and CD4 ϩ CD25 ϩ T
cells isolated from tolerant mice are hyporesponsive to Ag stimulation
On a functional level, Treg cells can inhibit the proliferation of the whole T cell population in response to cognate Ag (32) . To assess the impact on proliferation of CD4 ϩ CD25 ϩ T cells induced by DC administration, splenocytes from tolerant, rejecting, and control mice were cocultured with bmDC derived from female CBA/Ca mice pulsed with various concentrations of the H-2E k -restricted Dby peptide (1-100 nM). The splenocytes from tolerant groups appeared profoundly inhibited in their proliferative response to Ag compared with control mice (Fig. 5A) .
To clarify which subpopulation of T cells expresses regulatory activity, CD4 ϩ CD25 ϩ and CD4 ϩ CD25 Ϫ T cells were purified from tolerant mice by magnetic separation. Both populations were stimulated with mitomycin C-treated female CBA/Ca DC, pulsed with 100 nM Dby peptide. Although CD4 ϩ CD25 ϩ T cells were refractory to Ag stimulation, removal of the CD4 ϩ CD25 ϩ cells from the CD4 ϩ population relieved suppression, albeit only partially (Fig. 5B) . The proliferative response of the CD4 ϩ CD25
Ϫ population was ϳ20 -50% of that observed among naive T cells, suggesting that administration of DC may induce some level of anergy among Ag-specific T cells, as well as the de novo induction of Treg cells.
Hyporesponsiveness to Ag is TGF-␤ dependent
Finally, we assessed the extent to which certain regulatory cytokines contribute to maintenance of the hyporesponsive state, by using mAb specific for the IL-10R (clone 1B1.2) and TGF-␤ (clone 11D11.16.8). Both IL-10 and TGF-␤ have, in some instances, been implicated in the activity of CD4 ϩ CD25 ϩ Treg cells (33, 34) . Addition of anti-TGF-␤, but not anti-IL-10R, to a Dby a Total viable splenocytes were enumerated by trypan blue exclusion and percentages were obtained by FACS staining using mAb specific for CD4 and CD25 (means Ϯ SD of three samples). specific in vitro proliferation assay significantly reversed the suppression (Fig. 5C) , indicating a role for TGF-␤ in maintaining the hyporesponsive state, perhaps by increasing the activation threshold of TCR triggering (35) .
Discussion
Since our first description of dominant and infectious tolerance in 1993 (36), we have sought to explain how the tolerated graft is able to induce and sustain Treg cells throughout its tenure. Treg cells were induced in the face of saturating levels of blockading CD4 mAb and the form of Ag to sustain this regulation could only have been presented by APC which had experienced neither danger nor maturation signals. The recent finding that sustained adjuvant-free Ag (4) or danger-free APL (5) can induce foxp3 ϩ Treg cells de novo, led us to propose that tolerated grafts provide a continuous source of danger-free Ag which, when processed by APC, is capable of delivering persistent, partial signals to T cells, so as to induce tolerance, anergy, and regulation, as well as providing sufficient signals to sustain active Treg cells. The experiments described here represent a direct test of this hypothesis by examining whether DC, incapacitated for their ability to activate naive T cells, are able to induce tolerance by driving regulation.
We used a TCR-transgenic mouse model as a platform to focus on the mechanisms underlying peripheral tolerance. Intravenous administration of 2 ϫ 10 6 1␣,25(OH) 2 D 3 -conditioned male DC into female A1.RAG-1 Ϫ/Ϫ mice resulted in dominant tolerance among peripheral T cells, as evidenced both by acceptance of male skin grafts and the failure of nontolerant, naive splenocytes to abrogate the tolerant state upon adoptive transfer. Tolerance arising from DC administration was associated with the appearance of a population of profoundly hyporesponsive Treg cells in the spleen and tolerated graft, but not within the host thymus. These CD4 ϩ Treg cells were characterized by their expression of foxp3 and the cell surface markers CD25, CD103, and GITR. Not surprisingly, tolerance could not be induced with female DC, indicating that tolerance was entirely Ag dependent. In addition, tolerance could not be achieved when using male DC of a different MHC haplotype, indicating that reprocessing of the male Dby Ag by host DC was not sufficient to account for the induction of tolerance in this model, although it is presumably responsible for its ongoing maintenance following the demise of the donor DC.
Although not formally the subject of this study, our microarray analysis of the DC populations used provides a starting point for the identification of genes that contribute to a protolerogenic phenotype. That DCv retain the same capacity as DCo to induce tolerance, irrespective of their exposure to LPS, is particularly significant in this respect because genes whose expression is modulated differentially compared with DCo ϩ may be considered likely candidates for tipping the balance between tolerance and immunity (Table I , section I). Furthermore, those genes universally modulated by LPS are evidently insufficient to override the tolerogenic potential of DC (Table I, (Table I , sections I and V). Because paired Ig-like receptor-B has only recently been designated the ortholog of the human inhibitory receptors Ig-like transcript 3/4, the corresponding gene was not included during the design of our custom microarray. Nevertheless, Serial Analysis of Gene Expression analysis of DCo and DCv in our laboratory likewise reveals that 1␣,25(OH) 2 D 3 has no apparent impact on expression of this gene, unlike exposure to IL-10, which strongly induces its up-regulation. These findings are consistent with those of Penna and colleagues (37) whose studies of human 1␣,25(OH) 2 D 3 -treated DC reveal that the expression of ILT3 is dispensable for the induction of Treg cells.
The findings of the current work extend previous observations of tolerance in mice systemically treated with vitamin D 3 and mycophenolate mofetil (38) . In this study, tolerance was associated with increased numbers of CD4 ϩ CD25 ϩ T cells, together with DC displaying reduced costimulatory signals. It is possible that the tolerogenic phenotype displayed by the DC arose as a result of an inhibitory feedback loop between Treg cells and DC (39) , the Treg cells being responsible for downregulating costimulatory molecules on the APC (40) . We have shown that both immature DC, as well as DC conditioned with 1␣,25(OH) 2 D 3 , are able to induce CD4 ϩ CD25 ϩ T cells, as postulated by Adorini et al. (41) , based on studies in the human. Nevertheless, DCv may differ from human myeloid DC treated with 1␣,25(OH) 2 D 3 in terms of their capacity to recruit preexisting natural Treg cells to sites of inflammation, because 1␣,25(OH) 2 D 3 not only down-modulated CCL17, as previously described (22) , but also failed to augment expression of the chemokine CCL22 (Table I , section I), which, like CCL17, has been shown to contribute to the recruitment of foxp3 ϩ Treg cells through ligation of CCR4.
Tolerized mice contained normal numbers of T cells, indicating that the administration of Ag-laden DC had not resulted in systemic T cell deletion. Nevertheless, tolerant T cells exhibited a profound hyporesponsiveness in vitro that was partially reversible upon addition of mAb specific for TGF-␤, but not IL-10R. Interestingly, administration of neutralizing mAb specific for TGF-␤ failed to inhibit the induction of tolerance with DCo and DCv even though the same treatment regime abrogated tolerance induced using mAb specific for CD4 and CD8 (31) (data not shown). Although these experiments argue against a role for TGF-␤ in the induction phase, we cannot exclude its involvement in the ongoing maintenance of the tolerant state, although, given that suppression is only partially reversible in vitro (Fig. 5C ), other mechanisms are likely to be involved. Irrespective of the role of TGF-␤ in their physiology, CD4 ϩ CD25 ϩ T cells induced in these mice appear to be suppressive for the CD4 ϩ CD25 Ϫ population, since the latter, when isolated from CD4 ϩ CD25 ϩ T cells, exhibit some capacity to proliferate in response to Ag, albeit reduced by comparison with naive T cells.
Our gene expression data lend credence to the hypothesis that vitamin D 3 acts by retaining DC in a state which, while clearly distinct from immaturity, is incompatible with full signaling potential, because a number of key immunogenic molecules are not up-regulated by DCv ϩ . These findings embrace other studies which have documented the induction of tolerance upon administration of APL (5), apoptotic material (25) , and infectious tolerance due to the continuous release of graft Ags (2) . Each of these scenarios may be anticipated to involve the presentation of Ag by steady state, quiescent DC. It should be noted, however, that immature and 1␣,25(OH) 2 D 3 -treated DC did not display identical gene expression profiles, suggesting that 1␣,25(OH) 2 D 3 does not simply maintain the DC in a frozen state (14) . Clearly, any effector function may be the result of subtle combinatorial changes in gene expression, which individually may not appear significant, but together act synergistically to greatly affect outcome. In addition, we recognize that although 1␣,25(OH) 2 D 3 ensures a reduced expression of activation signals (42, 43) , its action may also be due, in part, to concomitant up-regulation of those inhibitory molecules not represented on the custom chip (43) .
In conclusion, the current study demonstrates unequivocally that DC, incapacitated so as to avoid full signaling potential, either through their immaturity or through pharmacological modulation, are capable of inducing tolerance and regulation among naive CD4 ϩ T cells. These findings support the notion that immature host DC acquiring alloantigens under the noninflammatory conditions that prevail following healing of an allograft may sustain dominant tolerance by the steady state induction of Treg cells. Infectious tolerance may, therefore, involve a continuous process of conversion of naive T cells to regulatory function, resulting from exposure to donor graft Ags processed by quiescent host DC. Such insights into DC-mediated generation of CD4 ϩ CD25 ϩ Treg cells in vivo may spawn therapeutic strategies to ensure selective vaccination for the generation of Treg cells.
